지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2018.1
- 수록면
- 23 - 26 (4page)
이용수
초록· 키워드
오류제보하기
A 22-year-old male patient was diagnosed with autosomal dominant polycystic kidney disease(ADPKD). He received conservative treatment with an angiotensin-converting enzyme inhibitor. Two years later, oral therapy, consisting of 60 mg tolvaptan per day, was initiated. Compared with height-adjusted total kidney volume, the rate of kidney growth reduced significantly from 7.33% to 0.66% annually, since commencement of the tolvaptan therapy. The liver enzyme profile and serum sodium level and osmolality were constantly within normal ranges. In Korea, this is the first reported case of a patient with ADPKD who received tolvaptan treatment for more than 1 year. This case demonstrates that long-term tolvaptan treatment appears to be safe, well tolerated, and effective for ADPKD.
목차
등록된 정보가 없습니다.
참고문헌 (10)
참고문헌 신청
Levey AS / 2009 / A new equation to estimate glomerular filtration rate / Annals of internal medicine 150:604~612
Gabow PA / 1993 / Autosomal dominant polycystic kidney disease / Am J Kidney Dis 22:511~512
Gattone VH, 2nd / 2003 / Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist / Nat Med 9:1323~1326
Gabow PA / 1993 / Autosomal dominant polycystic kidney disease / N Engl J Med 329:332~342
Torres VE / 2007 / Autosomal dominant polycystic kidney disease / Lancet 369:1287~1301
Gabow PA / 1993 / Autosomal dominant polycystic kidney disease / Am J Kidney Dis 22:511~512
Gattone VH, 2nd / 2003 / Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist / Nat Med 9:1323~1326
Gabow PA / 1993 / Autosomal dominant polycystic kidney disease / N Engl J Med 329:332~342
Torres VE / 2007 / Autosomal dominant polycystic kidney disease / Lancet 369:1287~1301
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Feasibility of artificial intelligence-based decision supporting system in tolvaptan prescription for autosomal dominant polycystic kidney disease
Investigative and Clinical Urology
2023 .05
-
Clinical Characteristics and Surgical Outcomes of Kidney Transplantation (KT) in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients
대한외과학회 학술대회 초록집
2021 .05
-
Autosomal Dominant Polycystic Kidney Desease Coexisting with Renal Dysplasia. First Case Described and Followed Since Prenatal Period
Childhood Kidney Diseases
2018 .01
-
Hypokalemic Hypertension Leading to a Diagnosis of Autosomal Dominant Polycystic Kidney Disease
Electrolytes & Blood Pressure
2016 .01
-
Practical Issues in the Management of Polycystic Kidney Disease: Blood Pressure and Water Balance
Electrolytes & Blood Pressure
2022 .06
-
Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease
Journal of Korean Medical Science
2020 .01
-
상염색체우성 다낭신 치료의 최신 지견
대한내과학회지
2015 .01
-
Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression
Kidney Research and Clinical Practice
2022 .11
-
Cerebral Microbleeds in Autosomal Dominant Polycystic Kidney Disease
대한뇌졸중학회지
2020 .01
-
Obturator hernia in autosomal dominant polycystic kidney disease
Kidney Research and Clinical Practice
2018 .01
-
Genetic diagnosis of autosomal dominant polycystic kidney disease: linkage analysis versus direct mutation analysis
Kidney Research and Clinical Practice
2016 .01
-
Are you ready to accompany autosomal dominant polycystic kidney disease patients in their treatment journey? Real practice for selecting rapid progressors and treatment with tolvaptan
고신대학교 의과대학 학술지
2023 .06
-
The Natural Course of Total Kidney Volume in Patients with Autosomal Dominant Polycystic Kidney Disease undergoing Hemodialysis
고신대학교 의과대학 학술지
2021 .12
-
Exploring the Molecular Pathways of Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease Using Proteomic Analysis
대한외과학회 학술대회 초록집
2023 .05
-
Newly Detected PKHD1 Gene Mutation in a Newborn with Fatal Autosomal Recessive Polycystic Kidney Disease
Neonatal medicine
2015 .01
-
Prenatal Diagnosis of a Fatal Case of Fetal Autosomal Dominant Polycystic Kidney Disease
Perinatology
2023 .03
-
Sonographic Growth Charts for Kidney Length in Normal Korean Children: A Prospective Observational Study
Journal of Korean Medical Science
2016 .01
-
Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period
Kidney Research and Clinical Practice
2023 .03
-
The management of polycystic liver disease by tolvaptan
Clinical and Molecular Hepatology
2020 .01
-
Safety and feasibility of synchronous unilateral nephrectomy and contralateral heminephrectomy for extremely severe autosomal dominant polycystic kidney disease: Techniques and outcome
Investigative and Clinical Urology
2022 .05
이 논문의 저자 정보
최근 본 자료
댓글(0)
0